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Bioassays play a central role in effect-directed analysis (EDA), and their selection and application have to consider
rather specific aspects of this approach. Meanwhile, bioassays with zebrafish, an established model organism in
different research areas, are increasingly being utilized in EDA. Aiming to contribute for the optimal application of
zebrafish bioassays in EDA, this review provides a critical overview of previous EDA investigations that applied
zebrafish bioassays, discusses the potential contribution of such methods for EDA and proposes strategies to
improve future studies. Over the last 10 years, zebrafish bioassays have guided EDA of natural products and environmental
samples. The great majority of studies performed bioassays with embryos and early larvae, which allowed small-scale and
low-volume experimental setups, minimized sample use and reduced workload. Biotesting strategies applied zebrafish
bioassays as either the only method guiding EDA or instead integrated into multiple bioassay approaches. Furthermore,
tiered biotesting applied zebrafish methods in both screening phase as well as for further investigations. For dosing, most
of the studies performed solvent exchange of extracts and fractions to dimethyl sulfoxide (DMSO) as carrier. However,
high DMSO concentrations were required for the testing of complex matrix extracts, indicating that future studies might
benefit from the evaluation of alternative carrier solvents or passive dosing. Surprisingly, only a few studies reported the
evaluation of process blanks, indicating a need to improve and standardize methods for blank preparation and biotesting.
Regarding evaluated endpoints, while acute toxicity brought limited information, the assessment of specific endpoints
was of strong value for bioactivity identification. Therefore, the bioassay specificity and sensitivity to identify the
investigated bioactivity are important criteria in EDA. Additionally, it might be necessary to characterize the most
adequate exposure windows and assessment setups for bioactivity identification. Finally, a great advantage of
zebrafish bioassays in EDA of environmental samples is the availability of mechanism- and endpoint-specific methods
for the identification of important classes of contaminants. The evaluation of mechanism-specific endpoints in EDA is
considered to be a promising strategy to facilitate the integration of EDA into weight-of-evidence approaches, ultimately
contributing for the identification of environmental contaminants causing bioassay and ecological effects.
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Introduction
Zebrafish is a model vertebrate organism broadly applied
in biological sciences, being one of the most important
organisms that is used in different research areas as gen-
etics, developmental biology and ecotoxicology [1]. More
recently, its versatility has also been recognized by* Correspondence: carolina.dipaolo@bio5.rwth-aachen.de
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in any medium, provided the original work is pchemists, which provides an opportunity to enhance
interdisciplinary studies involving biology and chemistry
[2] as in effect-directed analysis (EDA) [3].Bioassays in EDA
EDA, bioassay-guided fractionation and similar ap-
proaches are testing procedures applied to identify the
individual bioactive compounds contained in highly
complex matrices, such as natural products and environ-
mental samples. Bioassays play a central role in EDA
since biological activity directs the chemical fraction-
ation and analysis steps as well as the testing strategy.an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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the complexity of the original mixture, bioassays are
needed to identify the active fractions and to guide fur-
ther fractionation steps. Target and non-target chemical
analyses are applied to select candidates and identify
bioactive substances. Bioassays again play an important
role in the confirmation phase, for biotesting of the pure
substance identified as the bioactive compound [3-5].
Therefore, bioassay selection for EDA studies has to
consider aspects that are rather specific to this applica-
tion. For accurate identification of bioactive fractions,
the bioassays should present high sensitivity and low in-
ternal test variability and be able to detect different che-
micals that address similar endpoints or modes of
action. Furthermore, due to limited sample amounts and
large numbers of fractions to be tested, high-throughput
low-volume bioassays are required [5].
Thus, in vitro bioassays are often selected for EDA
studies; however, certain bioactivities require the organ
or organism level for their proper identification, as for
compounds in which metabolism plays an important
role by interfering with formation or transformation of
bioactive metabolites and bioaccumulation profiles [6].
These are the cases when bioassays with zebrafish early-
life stages are considered to be of great value since they
combine the organism-level endpoints with advantages of
the in vitro format. Furthermore, biotesting strategies inte-
grating organism-based and in vitro bioassays are expected
to cover a broad range of bioeffects and related toxicants.
The resulting diagnostic power strongly supports the iden-
tification of specific toxicants in EDA case studies [7].
Zebrafish model and bioassays in EDA
The zebrafish Danio rerio exhibits characteristics that
make it a very attractive research model, including small
size, ease of culture, high fecundity, rapid development,
external fertilization and development, and transparency
of the embryo. Bioassays with zebrafish embryos and lar-
vae have further advantages that fit very well to EDA re-
quirements. While these tests are relevant to evaluate
acute [8] and chronic [9] effects in later life stages, the ex-
perimental setup exhibits several in vitro test characteris-
tics, including a reduced volume of sample for testing and
potential for high-throughput applications. Experiments
with early life stages often do not require animal test
authorization, and no external feeding is needed by em-
bryos and larvae [1].
The zebrafish success as a model organism is in great
part due to the work of pioneer scientists between the
late 1960s and mid-1990s, as George Streisinger, who
established the first zebrafish models and performed pi-
oneer works on its genetics and developmental biology
[10-12]; Charles Kimmel’s descriptions of the cellular
fate map [13] and the stages of development [14] inembryos; and Christiane Nüsslein-Volhard, who per-
formed a large-scale mutant screen to identify genes for
vertebrate development control [15,16]. Following these
ground-breaking studies, there was evident increase in
the use of zebrafish in research [17], resulting in the se-
quencing of its genome [18], extensive information on
its genetics, genomics, phenotypic and developmental
biology [19], and the establishment of thousands of wild-
type and transgenic zebrafish lines [20,21].
Importantly, zebrafish embryos and early larvae might
be used to replace or refine experiments with adult fish,
being increasingly applied in ecotoxicology to evaluate
the toxicity of chemicals, plant protection products, bio-
cides, pharmaceuticals, wastewater effluents and various
aqueous environmental samples, and to assess sediment
toxicity [1,22-24]. Recently, zebrafish embryo toxicity as-
says have been integrated in biotest batteries in environ-
mental monitoring programmes, as the Joint Danube
Survey [25] and the working group on bioassays of the
NORMAN network [26]. Fish bioassays also play an im-
portant role in the implementation of the European
Water Framework Directive (WFD) since they provide
data for the derivation of environmental quality stan-
dards (EQS) and might represent a sensitive taxon for
substances with specific modes of action [27]. Besides,
biotests with fish are also included among recommended
bioeffect-based tools for environmental assessment in the
context of the WFD and the European Marine Strategy
Framework Directive (MSFD) [7]. Consequently, current
EU projects are investigating the contribution of zebrafish
bioassays for water quality assessment and EDA of envir-
onmental samples, with focus on specific modes of action,
mechanism-specific endpoints and adverse-outcome path-
ways [28,29]. Such initiatives are supported by the pro-
posal that EDA contributes as an additional line of
evidence in weight-of-evidence frameworks, such as the
triad approach, ultimately leading to the identification of
the contaminants responsible for the toxic effects ob-
served in bioassays and the environment [30,31].
Context and objectives of this review
This review was developed in the context of the Marie
Curie Initial Training Network ‘EDA-EMERGE - Novel
tools in effect-directed analysis for identifying and moni-
toring emerging toxicants on a European scale’ , funded by
the European Commission within the Seventh Framework
Programme for Research [28]. The literature review aimed
to provide an overview of previous EDA investigations
that applied bioassays with zebrafish, critically evaluating
their objectives, methods, biotesting strategy and out-
comes; discuss the potential contribution of further zebra-
fish bioassays for EDA; and propose strategies that might
help optimizing the integration of such biotools into fu-
ture EDA studies investigating environmental samples.
Di Paolo et al. Environmental Sciences Europe  (2015) 27:8 Page 3 of 11In order to meet these objectives, the literature was
searched using the online tools Thomson Reuters Web of
Science (WoS), ScienceDirect (SD) and Google Scholar
(GS). In WoS, the terms were searched by topic (searching
the fields Title, Abstract, Author Keywords and Keywords
Plus® per record) in all databases, and in SD and GS, the
terms were searched in all fields. The searches were done
for publications in all years, except where indicated. The
zebrafish terms used for search or filtration were a com-
bination of ‘zebrafish’ or ‘zebra fish’ or ‘Danio rerio’. The
EDA and life stage search terms are detailed below.
Zebrafish potential for EDA application
Zebrafish in EDA-relevant research areas
The application of the zebrafish model in EDA-related
research areas was verified by search in WoS for the
zebrafish terms as keywords in topic/all databases,
followed by classification per research area (Figure 1).
The search period was limited to between 2004 and
2014, to be in agreement with the publication years of
EDA studies evaluated in this review. Outcomes are in
good agreement with a recent review that applied much
more sophisticated search strategy [17], indicating the
usefulness of WoS for a first evaluation of research
areas. Among the research areas strongly related to
EDA, toxicology (8.9%) and pharmacology (9.0%) were
each referred by circa 9% of the publications, whileFigure 1 Records for the zebrafish terms, filtered by publication period
of records per period: 63,851. Search done in October 2014 (Web of Science).environmental sciences and ecology (3.0%) and chemis-
try (1.9%) were referred by a lower percentage. The
prevalent research fields addressed by more than 20% of
publications were mostly those that traditionally apply
zebrafish, as genetics and heredity (40.6%), biochemistry
and molecular biology (33.9%), developmental biology
(30.7%), and zoology (24.6%)
Life stages referred to by research studies
The use of different life stages in studies with zebrafish
was estimated by search for the zebrafish terms filtered
by the life stage terms ‘embryo*’, ‘larva*’, ‘juvenile*’,
‘adult*’ and combinations of those. Again, the search
period was limited to the publication years of reviewed
EDA studies (2004 to 2014). As illustrated in Figure 2,
more than half of the studies with zebrafish refer to em-
bryos (52.6%) and almost one fourth of these mentioned
also either adults or larvae, corresponding to 4.0% and
7.4% of total publications, respectively. The occurrence
of studies mentioning adults (13.4%) and larvae (11.9%)
was also representative, while circa 1% only referred to
juvenile life stages.
EDA studies integrating zebrafish bioassays
Due to the heterogeneous nomenclature found in the lit-
erature, different EDA terms as listed in Weller 2012 [4]
plus the term ‘fractionation’ were searched in quotation(2004 to 2014), classified according to research area. Total number
Figure 2 Records for the zebrafish and life stage terms, filtered by publication period (2004 to 2014). The life stage terms are ‘embryo*’ ,
‘larva*’ , ‘juvenile*’ , ‘adult*’ or combinations of these. Total number of records per period: 63,851. Search done in October 2014 (Web of Science).
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the zebrafish terms mentioned above, resulting publica-
tions were screened for confirmation of the searched
content. Review papers, or studies that did not include
the EDA procedure or zebrafish bioassays, were ex-
cluded. Two studies that followed procedures for toxicity
identification evaluation (TIE) [32,33] instead of EDA
were included since the similarities between both ap-
proaches [5] make them relevant for this review. In total,
29 publications were found (Table 1), which were care-
fully evaluated for research area, objective, investigated
matrix, bioassay endpoint and setup, biotesting strategy,
and study outcomes.
Research areas and investigated matrices
Two main fields were prevalent among EDA studies
using zebrafish bioassays: drug discovery from natural
products and environmental toxicology (Figure 3). Natural
product studies aimed to identify bioactive compounds for
pharmacological applications, investigating mostly plant
extracts [19,34-45] but also extracts of bacteria [46],
cyanobacteria and algae [47], seaweed [48] and marine or-
ganisms [49]. Environmental toxicology studies aimed to
identify the toxic compounds in various environmental
samples, including marine and fluvial sediments [50-52],
soil [53], cyanobacteria and algae [54,55], industrial efflu-
ent [33], rubber tyre leachates [32], oil sand process waters
[56,57] and river pore water [58]. Finally, fish skin extracts
were investigated in a behavioural sciences study [59].Prevalent life stages and exposure setups
EDA studies applied mostly bioassays with early em-
bryos and larvae, following exposure to chemical ex-
tracts and fractions in multiwell-plates, often with
exposure of several individuals in the same well (Table 2).
Zebrafish up to 5 days post fertilization (dpf) were the
life stages mostly applied, except for experiments that
extended the assays up to 6 to 7 dpf [34,49,53,56,57] or
a few studies with adults [33,47,59]. Environmental toxi-
cology studies for the most part performed exposure not
only in 24-well plates (200 μL to 2 mL per embryo or
larva) but also in crystallization dishes, scintillation vials
or beakers (450 μL to 5 mL per embryo or larva, 40 to
300 mL per adult), while natural product studies were
performed exclusively in multiwell-plate setup (<100 to
250 μL per embryo or larva). The exposure of several in-
dividuals in the same well or vessel was observed for
most of the studies, reflecting the need to reduce work-
load for EDA biotesting.
Biotesting strategy
The EDA investigations guided only by zebrafish bioassays
followed either a single test setup (e.g. [36,53,55-57]) or a
combination of methods (e.g. [44,52]) to evaluate end-
points in zebrafish. Other studies applied methods with
additional experimental models, mostly cell-based (e.g.
[19,45,51]) but also bacteria [46,50] and rodent [39] assays.
When the application of multiple biossays aimed to evalu-
ate distinct bioactivities, the tests were mostly performed
Table 1 Records for the EDA terms after filtering and after confirming that studies performed EDA
Search terms WoS, all databases
by topic (n)
WoS, filtered by
zebrafish terms (n)
WoS, confirmed content (n) Confirmed papers in
WoS + SD + GS (n)
Bioassay(−)guided fractionation 5,134 14 8 9
Effect(−)directed analysis 189 14 3 5
Bioassay(−)guided isolation 454 9 7 8
Bioassay(−)directed fractionation 464 8 0 1
Toxicity(−)identification evaluation 346 2 1 2
Bioactivity(−)screening 92 3 2 2
Activity(−)guided fractionation 641 2 1 1
Bioactivity(−)guided fractionation 492 1 0 2
Bio(−)guided fractionation 136 1 1 1
Fractionation 232,733 84 15 21
Totala 29
The sum of papers from WoS, ScienceDirect (SD) and Google Scholar (GS) after confirmation of content is also presented. Search done in October 2014. aThe total
number differs from the sum since some studies resulted in more than one search.
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occurrence of different toxicity mechanisms [50,51] or ef-
fects on different trophic levels in the two TIE studies
[32,33]. When instead the aim of multiple methods was to
analyse different aspects of the same bioactivity or toxicity
mechanism, there was the prevalence of tiered approach
biotesting [19,39,45]. When applied in screening phase,
zebrafish bioassays aimed to identify active fractions by
organism-level endpoints, which were later further investi-
gated by additional methods with zebrafish [52] or with
other experimental models [19,45]. As an example, zeb-
rafish bioassays were applied to screen extracts and
fractions for anti-angiogenic effects, followed by furtherFigure 3 EDA studies applying zebrafish bioassays for the investigati
studies that were evaluated in the literature review identified per main rese
Google Scholar, October 2014).investigations on human cells and transgenic zebrafish
embryos [19]. On the other hand, zebrafish bioassays ap-
plied only as secondary tests aimed mostly at the confirm-
ation of bioeffect occurrence at the organism level [49] or
to evaluate the occurrence of acute toxicity in fish [46,47].
Use of solvents in bioassays
In biotesting, solvents were used for transference of sam-
ples into exposure vessels or as carriers. The first approach
was applied using acetonitrile [55] or ethanol [54], includ-
ing also solvent control conditions, and proceeding to solv-
ent evaporation before adding exposure media. The use of
solvents as carriers in bioassays showed the prevalence ofon of natural products and environmental samples. Number of
arch area and year of publication (Web of Science, ScienceDirect and
Table 2 Exposure setup for studies on natural products or environmental toxicology
Exposure format Fish per well
or vessel (n)
Natural products Environmental toxicology
Medium volume per fish
and respective reference
Medium volume per fish
and respective reference
96-well plates 1 100 μL [19,30,34,39,42] 100 μL [50]
4 <100 μL [45] -
24-well plates 1 - 2 mL [32]
5 n.a. [46] 200 μL [51,54,55]
10 100 to 250 μL [38,40,43] -
15 <100 μL [41] -
25 <100 μL [35] -
12-well plates 10 n.a. [48,49] -
6-well plates 25 to 30 n.a. [36,37] -
Beakers, dishes, vials 5 to 40 40 mLb [47] 0.45 to 5 mLa [53,56-58], 300 to 1,000 mLb [33,59]
n.a. means information not available; abioassay with embryos and larvae, bbioassays with adults.
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from 0.01% [35], 0.1% [31,45], 0.2% [26], 0.5% [46,47], 1%
[33,48-50] up to 2% [51]. In addition, ethanol was also used
as a carrier by a few studies, in concentrations of 0.001%
for experiments with larvae [40,41] or 0.435% for experi-
ments with zebrafish adults [42].
It is relevant to mention that the different procedures
for extraction, cleanup, pre-concentration and fraction-
ation of samples, already extensively reviewed elsewhere
[3,4,60], also involve the use of different solvents and
chemicals. Criteria for the use of solvents in EDA studies
are the following: low or lack of toxicity in the biotest,
the capacity of the solvent to dissolve complex extracts
and fractions and the possibility to use the solvent in
chemical analysis. The latter is the precondition to make
sure that the chemical mixture tested in the bioassay re-
sembles the mixture evaluated in chemical analysis.
While DMSO excellently meets the first criterion, it is
less suitable for dissolving complex mixtures when com-
pared to other possible alternatives, and it completely
fails the criterion related to the use in chemical analysis.
Thus, the investigation of other solvents as possible car-
riers for exposure in zebrafish embryo testing might help
to reduce possible artefacts during solvent exchange to
DMSO. The evaluation of process blanks in order to ex-
clude artefact toxicity is crucial for successful EDA and
will be discussed below.
Positive/negative controls and biotesting of blanks
Positive control conditions that were specific to the eval-
uated endpoints were often described. For that, there
was exposure of the zebrafish to compounds known to
cause specific effects such as anti-convulsant activity
[39], glucose uptake [45], pro-angiogenesis [36,37], anti-
angiogenesis [19,44], or estrogenic effects [52,56]. Re-
garding negative control conditions, most of the studiesreported the testing of solvent controls in the same
concentration as for the respective sample testing
[19,32,34,35,38-40,43,44,47,49-51,53,55]. Some studies
have additionally evaluated a medium only condition
in addition to the solvent control [36,37,42,54,56,57].
The preparation and biotesting of blanks was de-
scribed only in few of the evaluated EDA studies and in
the two TIE studies. In the EDA studies, there was sub-
mission of the respective solvents [51,53,56,57] or of
HPLC-grade water [58] through the same or part of the
procedures that were applied to samples (i.e. sample
preparation, extraction, fractionation). The TIE studies
described blank preparation by treatment of milliQ
water [32] or 0.1 M KCl solution [33] in the same way
as samples for all procedures. In all these studies, the
prepared blanks were evaluated in bioassays in the same
way as done for samples and fractions. Another strategy
was the use of a fraction that showed to be negative for
the evaluated effect as a blank condition [45]. The ex-
change between elution solvents and DMSO was identi-
fied as a critical step since solvent traces might interfere
with bioassays; therefore, blank testing was suggested to
always be performed [51].
Investigated endpoints and studies outcomes
The specificity and sensitivity of bioassays and end-
points in identifying the bioactivity or adverse effects in
fractions were considered to be a key issue for the rele-
vance of zebrafish bioassays in EDA. Therefore, it is rec-
ommended to identify the critical aspects for endpoint
assessment, to optimize bioassays accordingly and to
demonstrate the validity of the bioassay by testing
known bioactive compounds [61]. The endpoints and
bioassays described in the different studies are summa-
rized in Table 3 and discussed in the context of respect-
ive study objectives and outcomes.
Table 3 Organism-level effects and assessed endpoints, according to the research area of studies and the investigated
sample matrices
Organism-level effect Endpoint Research area Matrix and reference
Acute toxicity Lethality and acute toxicity
(respiratory rate, heart rate,
movement) endpoints
Environmental toxicology Sediment extracts [50], industrial
effluents [33], rubber tyre leachates [32],
oil sand process waters [57]
Natural products Cyanobacteria and algae extracts [47],
seaweed hydrolysates [48]
Acute and developmental toxicity Lethal and morphological endpoints Environmental toxicology Sediment extracts [51], soil extracts [53],
microalgae extracts [54], cyanobacteria
extracts [55], river pore water extract [58]
Natural products Bacteria extracts [46]
Developmental toxicity Phenotypic endpoints Natural products Plant extracts [41]
Anti- or pro-angiogenesis ISV formation and/or function in
wild-type or fli1:EGFP zebrafish
Natural products Plant extracts [19,36-38,42-44]
Anti-angiogenesis and
anti-inflammatory
ISV outgrowth in fli1:EGFP, leukocyte
migration after tail transection
Natural products Plant extracts [40]
Glucose uptake Uptake of fluorescein-tagged
glucose bioprobe
Natural products Plant extracts [45]
Lipid storage modulation Uptake and metabolism
of fluorescent fatty acid
Natural products Heterofibrin molecules
from Spongia sp. [49]
Antioxidant effects ROS generation, cell death Natural products Plant extracts [35]
Estrogenicity GFP induction in tg(cyp19a1b-GFP) Environmental toxicology Sediment extracts [52]
vtg1 gene expession by qPCR Environmental toxicology Oil sand process waters [56]
Anti-convulsant Locomotor activity, electrographic
activity and epileptiform discharges
Natural products Plant extracts [39]
Inhibition of pentylenetetrazol-induced
seizure activity, WISH for brain
c-fos expression
Natural products Plant extracts [34]
Fear behaviour Alarm response, olfactory bulb
activation in Tα1:GCaMP2
Behavioural sciences Skin extracts [59]
ISV, intersegmental vessels; fli1:EGFP, transgenic zebrafish line with expression of enhanced green fluorescent protein marker in endothelial cells of vasculature;
ROS, reactive oxygen species; GFP, green fluorescent protein; WISH, whole-mount in situ hybridization; Tα1:GCaMP2, transgenic zebrafish line with expression of
the calcium indicator GCaM.
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Bioactive sediment fractions [51] and components par-
tially responsible for toxicity in oil sand process water
fractions [57] have been identified by acute toxicity bio-
assays. The two TIE studies reported inconsistent acute
toxicity of industrial effluents [33] and rubber tyre leach-
ates [32]. One study investigating seaweed hydrolysates
evaluated in vivo toxic potential through acute toxicity
testing [48].
It may be summarized that EDA studies that focused on
acute toxicity and lethality had only modest success in de-
termining active compounds. These are unspecific re-
sponses that might occur due to exposure to very broad
range of compounds; therefore, fractionation typically re-
sults in the distribution of toxicity over many different
fractions. However, also other unrelated factors might
have been involved, as for example, the high complexity of
investigated matrices in the reviewed studies. Neverthe-
less, acute toxicity testing might be a powerful tool in TIE,when applied to evaluate highly contaminated sites with
acute toxicity caused by compounds that are well charac-
terized [62].
Teratogenesis and developmental toxicity
Assessment of teratogenesis and developmental effects was
done in studies that identified the bioactive compounds
from microalgae, cyanobacteria and plant [41,54,55], river
pore water [58] and developmental toxicants in soil [53].
Most studies evaluated traditionally assessed morpho-
logical endpoints, while one investigation of plant fractions
focused on ectopic tail formation [41]. One study identified
embryotoxicity in sediment extracts but not in respective
fractions, which was attributed to losses of active com-
pound or of synergistic effect during fractionation [50].
An aspect shared by the successful studies was the me-
ticulous experimental characterization of the original
matrices and respective fractions regarding their terato-
genic effects and developmental toxicity potential. For
Di Paolo et al. Environmental Sciences Europe  (2015) 27:8 Page 8 of 11instance, there was the determination of the optimal ex-
posure period to identify a phenotype of interest that
caused minimal acute toxicity [41]. Characteristic
phenotypical effects were identified for specific fractions
[53], also on a dose-dependent manner [54,55]. Two
studies also investigated if additive or synergistic effects
occurred between different fractions [55] or between aryl
hydrocarbon receptor (AhR) agonists by co-exposure to
a CYP1A inhibitor [58].Angiogenesis modulation
Bioassays investigating pro- and anti-angiogenesis modu-
lation by different bioactive plants were the most frequent
studies in natural products. To this end, studies applied
wild-type zebrafish [30,42,43] or the transgenic fli1:EGFP
[63] zebrafish line [19,36-38,40], in which the zebrafish fli1
promoter drives the expression of enhanced green fluores-
cent protein in blood vessels. In wild-type zebrafish, stain-
ing of the vessels was applied to facilitate scoring [30,43],
while the transgenic line allowed in vivo observation of
the embryonic vasculature. Selected endpoints evaluated
specific cellular-morphological phenotypes, as interseg-
mental vessel formation. In these assays, the exposure
start and duration were set to the most sensitive develop-
mental windows related to the assessed endpoints.
All of the evaluated studies were successful in identify-
ing at least one bioactive compound causing angiogenesis
modulation, indicating that the identification of highly
specific endpoints on the organism level might be a good
requirement for the efficient use of zebrafish bioassays in
EDA. The use of transgenic zebrafish lines is also consid-
ered to be a great asset for studies that evaluate specific
morphological effects since it can facilitate endpoint ob-
servation and increase sensitivity of bioassays.Energy uptake and storage
EDA was successful in identifying known and novel
insulin-mimetic compounds in plants [45] with the con-
tribution of zebrafish bioassays to characterize glucose
uptake modulation. The study applied fluorescein-tagged
glucose bioprobes and measured fluorescence by micros-
copy imaging and microplate reader, obtaining dose- and
time-dependent responses. Another study applied a
fluorescent fatty acid analogue to evaluate fatty acid stor-
age modulation in zebrafish embryos by extracts from
marine sponge [49]. In this case, the characterization of ef-
fects was done by extraction of zebrafish lipids followed
by thin-layer chromatography. These studies demon-
strated that the use of fluorescent bioprobes is a good tool
to evaluate effects on the uptake and storage capacity of
zebrafish, allowing not only for qualitative but also quanti-
tative analysis of effects.Antioxidant effects
Zebrafish embryos were integrated into an EDA study
that identified and purified aloe vera polysaccharide with
protective effects against oxidative stress [35]. Tests with
zebrafish bioassays provided valuable information on
organism-level responses regarding the generation of re-
active oxygen species and oxidative stress-induced cell
death, which were observed in a dose response manner.
Estrogenicity assessment by gene expression
Estrogenic effects were investigated in extracts and frac-
tions of oil sand process waters by vitellogenin gene ex-
pression (vtg1) through quantitative polymerase chain
reaction (qPCR) in zebrafish early larvae [56]. Estrogeni-
city was also assessed by the use of transgenic zebrafish
embryos that exhibit green fluorescence protein expres-
sion in response to aromatase (cyp19a1b) gene induc-
tion, with confirmation of results by qPCR [52].
Gene expression analysis by qPCR showed to be a use-
ful EDA endpoint in zebrafish embryos and larvae when
background information allows the selection of specific
biomarker genes for the studied effect, as for estrogeni-
city. The evaluation of sets of genes by qPCR is consid-
ered to be a promising strategy for endocrine disruption
investigation, when following optimized experimental de-
sign regarding exposure intervals and evaluated zebrafish
developmental stages [64]. The transgenic zebrafish em-
bryos were also considered to be experimental models
compatible with EDA, and their integration in future stud-
ies is expected to be facilitated by automated image ana-
lysis procedures [52].
Neuroactivity and behaviour
EDA was applied to identify anticonvulsant compounds
present in plants, by co-exposure of evaluated samples
with a convulsant compound, followed by the analysis of
larvae total locomotor activity. Effects were assessed with
video-tracking and software analysis and with electro-
encephalogram recording analysis [39]. Another EDA
study of plant neuroactivity applied similar bioassays, in
combination with larvae whole-mount in situ hybridization
to assess increased brain c-fos gene expression as an indica-
tor of seizure onset and brain damage [34]. Both studies
identified anticonvulsant compounds, demonstrating
the usefulness of the zebrafish model to identify neu-
roactivity in EDA. Also for neuroactivity and behaviour,
the assessment of specific endpoints and setting the bio-
assay accordingly demonstrated to be an effective EDA
biotesting approach.
The identification of neuroactive compound extracts of a
mixture of red algae and cyanobacteria was investigated by
a biotest battery including in vitro and organism-level
methods [47]. Bioassays with zebrafish adults aimed at
evaluating the neurotoxic potential of the matrix. However,
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mortality, which provided only minor contribution to the
overall study outcomes.
The bioactive compounds responsible for fear behaviour
response in fish were investigated by the exposure of zeb-
rafish adults to fish skin extracts and fractions [59]. Video
tracking was used to quantify alarm behaviour by measur-
ing swimming speed and vertical position. The study iden-
tified the bioactive compound and proposed a new class of
odorants that trigger alarm behaviour in fish. This study
required the development of experimental setup and end-
point assessment that were specific to the evaluated be-
havioural alteration, confirming the importance of this
step also for behavioural assessment.
Summary and discussion
Over the last 10 years, EDA studies guided by zebrafish
bioassays have successfully identified bioactive or toxic
compounds present in diverse biological matrices or en-
vironmental samples. Embryos and early larvae were the
prevalent zebrafish life stages in these studies, with ex-
posure being done in multiwell-plates, often with several
individuals in the same well. In consequence, the sample
volume for biotesting was minimized and the workload
was reduced, which are important aspects in EDA. Zebra-
fish bioassays showed also versatility in terms of biotesting
strategy, being applied alone or as a part of biotest batter-
ies and in both screening phase as well as for further in-
vestigation of active fractions in tiered biotesting.
In spite of its limited capacity to dissolve complex
matrix extracts, DMSO was the main carrier solvent ap-
plied in zebrafish bioassays. As a result, it was used in
concentrations up to two orders of magnitude higher
than the recommended for single compound biotesting
(0.01%) [65]. Additionally, DMSO is not suitable for
chemical analysis, which restricts the characterization
of samples evaluated in biotesting. Therefore, the inves-
tigation of alternative carrier solvents would be an asset
for zebrafish bioassays in EDA. Passive dosing methods
are also promising options, as recently done in EDA in-
vestigation of sediments through the use of silicone rods
for dosing of extracts and fractions in algae bioassay
[66]. In fact, a loaded polymer silicone cast has success-
fully been integrated in zebrafish embryo assay for dos-
ing of polycyclic aromatic hydrocarbons [67].
The EDA procedures for sample extraction, cleanup,
pre-concentration and fractionation involve the use of
different solvents and chemicals. Nevertheless, while
most of the studies evaluated solvent and medium con-
trol conditions, the investigation of process blanks in
bioassays was reported only by a small number of stud-
ies. In addition, methods for blank preparation varied
considerably between these studies. Since the biotesting
of process blanks is crucial for effective EDA, there is aneed to improve and standardize the procedures for
their preparation and biotesting in future studies.
Most of the successful EDA studies applied specific
and sensitive bioassays evaluating molecular, morpho-
logical or behavioural endpoints. Some studies optimized
bioassays by identifying the most adequate exposure
windows and assessment setups to maximize the specific
endpoint response and minimize the interference of
acute toxicity [41]. Further improvements might be
achieved by advancing methods for the analysis of end-
points. For instance, the automated analysis of morpho-
logical phenotypes in transgenic or wild-type zebrafish
would reduce workload and increase reliability in EDA
[52]. Also, EDA of environmental samples would benefit
from the analysis of bioassay results in correlation with
previously characterized responses to specific classes of
pollutants. That is the case of gene expression analysis of
biomarker genes for specific mechanisms and modes of
action. When analysed in correlation with respective gene
modulation by known classes of compounds [68], bio-
marker gene responses might indicate the presence of cer-
tain classes of chemicals [69]. Similarly, EDA studies
evaluating behavioural phenotypes to identify neuroactiv-
ity might rely in the near future on databases of behav-
ioural profiles for different classes of compounds [70,71].
Such outcomes support the idea that EDA investiga-
tions of toxic environmental samples would benefit of
the application of endpoint- and mechanism-specific
methods with zebrafish. That is in fact a great advantage
since mechanism-specific toxicity methods with zebra-
fish are broadly developed, as for AhR-mediated toxicity
[72], genotoxicity [73] and neurotoxicity [74]. Further-
more, EDA guided by such zebrafish bioassays could in-
tegrate broader environmental assessment strategies,
complementing effect-based approaches [7] and weight-
of-evidence frameworks [30]. In this way, EDA would sup-
port the identification of contaminants causing bioassay
and ecological effects, and the clarification of links be-
tween ecosystem functioning and the responses at differ-
ent biological levels [30,62]. Finally, the evaluation of toxic
aquatic contaminants through EDA guided by zebrafish
bioassays might improve the protection of water bodies in
the context of the European WFD and MSFD [7,27]. In
conclusion, endpoint- and mechanism-specific zebrafish
bioassays are considered of great relevance not only for
guiding EDA studies but also for integrating EDA into en-
vironmental assessment and monitoring, ultimately con-
tributing for environmental quality improvement [7,75].
Conclusions
Zebrafish bioassays have successfully guided different
EDA studies; however, further method developments are
still needed. Alternative dosing procedures should be in-
vestigated, and process blank preparation and biotesting
Di Paolo et al. Environmental Sciences Europe  (2015) 27:8 Page 10 of 11should be standardized. Endpoint- and mechanism-
specific bioassays with embryos and larvae are consid-
ered to be the most promising zebrafish biotests for fu-
ture EDA of environmental samples. When integrated
into broader environmental assessment strategies, EDA
guided by specific zebrafish bioassays might support the
identification of compounds causing bioassay and eco-
logical effects, ultimately contributing for environmental
quality improvement.
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